DPW
ACAD icon

DiNuzzo Private Wealth’s Acadia Pharmaceuticals ACAD Stock Holding History

DiNuzzo Private Wealth’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506 Buy
20
+5
+33% +$110 ﹤0.01% 1098
2026
Q1 		$334 Hold
15
– – ﹤0.01% 1174
2025
Q4 		$401 Buy
15
+3
+25% +$72 ﹤0.01% 1141
2025
Q3 		$312 Buy
+12
New +$284 ﹤0.01% 1194

Other funds holding ACAD

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

DiNuzzo Private Wealth's ACAD Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Acadia Pharmaceuticals (ACAD) stake by 33% in Q2 2026, buying an estimated $110 and bringing the position to 20 shares worth $506. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

DiNuzzo Private Wealth first reported a position in ACAD in Q3 2025 and has held it in 4 quarters since. 73 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • DiNuzzo Private Wealth held 20 shares of Acadia Pharmaceuticals worth $506 as of Q2 2026.
  • DiNuzzo Private Wealth bought 5 Acadia Pharmaceuticals shares in Q2 2026, an estimated $110.
  • Acadia Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1098 holding.
  • DiNuzzo Private Wealth first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 73 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.